0 XP   0   0   0

Biosergen AS










Financial Health of Biosergen




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Biosergen AS
Buy, Hold or Sell?

Should you buy, hold or sell Biosergen?

I guess you are interested in Biosergen AS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Biosergen

Let's start. I'm going to help you getting a better view of Biosergen AS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Biosergen AS even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Biosergen AS is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Biosergen AS. The closing price on 2022-12-07 was kr1.036 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Biosergen AS Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Biosergen AS.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biosergen earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biosergen AS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y--541.0%+541.0%
1.1.2. Return on Assets

Shows how efficient Biosergen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • -58.5% Return on Assets means that Biosergen generated kr-0.58 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biosergen AS:

  • The MRQ is -58.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -31.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-58.5%TTM-31.3%-27.2%
TTM-31.3%YOY-1,524.5%+1,493.2%
TTM-31.3%5Y-529.0%+497.7%
5Y-529.0%10Y-529.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-58.5%-9.9%-48.6%
TTM-31.3%-8.9%-22.4%
YOY-1,524.5%-9.3%-1,515.2%
5Y-529.0%-11.7%-517.3%
10Y-529.0%-12.7%-516.3%
1.1.3. Return on Equity

Shows how efficient Biosergen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • -121.4% Return on Equity means Biosergen generated kr-1.21 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biosergen AS:

  • The MRQ is -121.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -52.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-121.4%TTM-52.7%-68.7%
TTM-52.7%YOY-16,627.3%+16,574.6%
TTM-52.7%5Y-5,577.6%+5,524.9%
5Y-5,577.6%10Y-5,577.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-121.4%-12.0%-109.4%
TTM-52.7%-11.5%-41.2%
YOY-16,627.3%-10.8%-16,616.5%
5Y-5,577.6%-14.2%-5,563.4%
10Y-5,577.6%-15.2%-5,562.4%

1.2. Operating Efficiency of Biosergen AS.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biosergen is operating .

  • Measures how much profit Biosergen makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biosergen AS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM78.9%-78.9%
TTM78.9%YOY-+78.9%
TTM78.9%5Y52.6%+26.3%
5Y52.6%10Y52.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM78.9%-271.0%+349.9%
YOY--325.9%+325.9%
5Y52.6%-454.0%+506.6%
10Y52.6%-537.1%+589.7%
1.2.2. Operating Ratio

Measures how efficient Biosergen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Biosergen AS:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.494-0.494
TTM0.494YOY-+0.494
TTM0.4945Y0.329+0.165
5Y0.32910Y0.3290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM0.4943.504-3.010
YOY-3.604-3.604
5Y0.3295.132-4.803
10Y0.3296.371-6.042

1.3. Liquidity of Biosergen AS.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biosergen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.93 means the company has kr1.93 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Biosergen AS:

  • The MRQ is 1.929. The company is able to pay all its short-term debts. +1
  • The TTM is 3.410. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.929TTM3.410-1.481
TTM3.410YOY3.313+0.097
TTM3.4105Y3.378+0.032
5Y3.37810Y3.3780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9295.117-3.188
TTM3.4105.755-2.345
YOY3.3135.854-2.541
5Y3.3786.511-3.133
10Y3.3786.222-2.844
1.3.2. Quick Ratio

Measures if Biosergen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • A Quick Ratio of 1.93 means the company can pay off kr1.93 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biosergen AS:

  • The MRQ is 1.929. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.811. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.929TTM2.811-0.882
TTM2.811YOY3.399-0.588
TTM2.8115Y3.007-0.196
5Y3.00710Y3.0070.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9294.284-2.355
TTM2.8114.664-1.853
YOY3.3994.787-1.388
5Y3.0075.218-2.211
10Y3.0075.182-2.175

1.4. Solvency of Biosergen AS.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biosergen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biosergen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.52 means that Biosergen assets are financed with 51.8% credit (debt) and the remaining percentage (100% - 51.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biosergen AS:

  • The MRQ is 0.518. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.320. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.518TTM0.320+0.198
TTM0.320YOY0.535-0.214
TTM0.3205Y0.392-0.071
5Y0.39210Y0.3920.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5180.278+0.240
TTM0.3200.277+0.043
YOY0.5350.306+0.229
5Y0.3920.367+0.025
10Y0.3920.403-0.011
1.4.2. Debt to Equity Ratio

Measures if Biosergen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 107.6% means that company has kr1.08 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biosergen AS:

  • The MRQ is 1.076. The company is able to pay all its debts with equity. +1
  • The TTM is 0.529. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.076TTM0.529+0.547
TTM0.529YOY5.096-4.566
TTM0.5295Y2.051-1.522
5Y2.05110Y2.0510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0760.315+0.761
TTM0.5290.317+0.212
YOY5.0960.319+4.777
5Y2.0510.403+1.648
10Y2.0510.462+1.589

2. Market Valuation of Biosergen AS

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Biosergen generates.

  • Above 15 is considered overpriced but always compare Biosergen to the Biotechnology industry mean.
  • A PE ratio of -24.57 means the investor is paying kr-24.57 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biosergen AS:

  • The EOD is -5.522. Company is losing money. -2
  • The MRQ is -24.572. Company is losing money. -2
  • The TTM is -33.983. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-5.522MRQ-24.572+19.050
MRQ-24.572TTM-33.983+9.411
TTM-33.983YOY-24.673-9.310
TTM-33.9835Y-30.880-3.103
5Y-30.88010Y-30.8800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.522-8.986+3.464
MRQ-24.572-9.792-14.780
TTM-33.983-16.243-17.740
YOY-24.673-20.876-3.797
5Y-30.880-16.665-14.215
10Y-30.880-14.732-16.148
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Biosergen.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Biosergen AS:

  • The MRQ is 66.415. Seems overpriced? -1
  • The TTM is 217.899. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ66.415TTM217.899-151.484
TTM217.899YOY-152.782+370.680
TTM217.8995Y143.763+74.136
5Y143.76310Y143.7630.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ66.415-0.032+66.447
TTM217.8990.004+217.895
YOY-152.7820.016-152.798
5Y143.7630.006+143.757
10Y143.7630.003+143.760

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biosergen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 29.82 means the investor is paying kr29.82 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Biosergen AS:

  • The EOD is 6.703. Seems overpriced? -1
  • The MRQ is 29.825. Seems overpriced? -1
  • The TTM is 16.886. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD6.703MRQ29.825-23.122
MRQ29.825TTM16.886+12.939
TTM16.886YOY4.269+12.617
TTM16.8865Y12.680+4.206
5Y12.68010Y12.6800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.7031.835+4.868
MRQ29.8252.006+27.819
TTM16.8862.774+14.112
YOY4.2693.453+0.816
5Y12.6802.713+9.967
10Y12.6802.402+10.278
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biosergen AS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.197-0.175-11%0.428-146%0.026-863%0.026-863%
Book Value Growth--0.7810.848-8%1.000-22%0.878-11%0.878-11%
Book Value Per Share--0.1550.422-63%0.428-64%0.424-64%0.424-64%
Book Value Per Share Growth---1.272-0.580-54%0.999-227%-0.264-79%-0.264-79%
Current Ratio--1.9293.410-43%3.313-42%3.378-43%3.378-43%
Debt To Asset Ratio--0.5180.320+62%0.535-3%0.392+32%0.392+32%
Debt To Equity Ratio--1.0760.529+103%5.096-79%2.051-48%2.051-48%
Dividend Per Share----0%-0%-0%-0%
Eps---0.188-0.205+9%-0.172-8%-0.194+3%-0.194+3%
Eps Growth---0.3700.252-247%0.323-215%0.266-239%0.266-239%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin---0.789-100%-0%0.526-100%0.526-100%
Operating Ratio---0.494-100%-0%0.329-100%0.329-100%
Pb Ratio6.703-345%29.82516.886+77%4.269+599%12.680+135%12.680+135%
Pe Ratio-5.522+78%-24.572-33.983+38%-24.673+0%-30.880+26%-30.880+26%
Peg Ratio--66.415217.899-70%-152.782+330%143.763-54%143.763-54%
Price Per Share1.036-345%4.6105.888-22%3.651+26%5.142-10%5.142-10%
Price To Total Gains Ratio-5.270+78%-23.452-35.942+53%8.544-375%-27.045+15%-27.045+15%
Profit Growth---93.933-88.353-6%-93.6300%-89.409-5%-89.409-5%
Quick Ratio--1.9292.811-31%3.399-43%3.007-36%3.007-36%
Return On Assets---0.585-0.313-46%-15.245+2508%-5.290+805%-5.290+805%
Return On Equity---1.214-0.527-57%-166.273+13599%-55.776+4495%-55.776+4495%
Total Gains Per Share---0.197-0.175-11%0.428-146%0.026-863%0.026-863%
Total Gains Per Share Growth---0.360-1.646+357%0.999-136%-1.117+210%-1.117+210%
Usd Book Value--631535.4001723866.300-63%1748182.050-64%1731971.550-64%1731971.550-64%
Usd Book Value Change Per Share---0.019-0.017-11%0.041-146%0.002-863%0.002-863%
Usd Book Value Per Share--0.0150.041-63%0.041-64%0.041-64%0.041-64%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.018-0.020+9%-0.017-8%-0.019+3%-0.019+3%
Usd Price Per Share0.100-345%0.4440.567-22%0.352+26%0.495-10%0.495-10%
Usd Profit---766548.000-636374.475-17%-1004409.000+31%-759052.650-1%-759052.650-1%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.019-0.017-11%0.041-146%0.002-863%0.002-863%
 EOD+3 -2MRQTTM+7 -22YOY+6 -215Y+10 -1910Y+10 -19

3.2. Fundamental Score

Let's check the fundamental score of Biosergen AS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.522
Price to Book Ratio (EOD)Between0-16.703
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.929
Current Ratio (MRQ)Greater than11.929
Debt to Asset Ratio (MRQ)Less than10.518
Debt to Equity Ratio (MRQ)Less than11.076
Return on Equity (MRQ)Greater than0.15-1.214
Return on Assets (MRQ)Greater than0.05-0.585
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Biosergen AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.050
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets13,617
Total Liabilities7,059
Total Stockholder Equity6,558
 As reported
Total Liabilities 7,059
Total Stockholder Equity+ 6,558
Total Assets = 13,617

Assets

Total Assets13,617
Total Current Assets13,617
Long-term Assets13,617
Total Current Assets
Cash And Cash Equivalents 5,720
Net Receivables 7,897
Total Current Assets  (as reported)13,617
Total Current Assets  (calculated)13,617
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,059
Long-term Liabilities0
Total Stockholder Equity6,558
Total Current Liabilities
Accounts payable 7,059
Total Current Liabilities  (as reported)7,059
Total Current Liabilities  (calculated)7,059
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock6,558
Total Stockholder Equity (as reported)6,558
Total Stockholder Equity (calculated)6,558
+/-0
Other
Cash and Short Term Investments 5,720
Common Stock Shares Outstanding 28,102
Liabilities and Stockholders Equity 7,059
Net Debt -5,720
Net Tangible Assets 6,558
Net Working Capital 6,558



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-31
> Total Assets 
275
43,213
40,244
29,486
18,458
13,617
13,61718,45829,48640,24443,213275
   > Total Current Assets 
275
43,213
40,244
32,649
18,458
13,617
13,61718,45832,64940,24443,213275
       Cash And Cash Equivalents 
0
41,277
36,838
21,665
9,702
5,720
5,7209,70221,66536,83841,2770
       Net Receivables 
1,670
1,670
557
6,337
8,756
7,897
7,8978,7566,3375571,6701,670
   > Long-term Assets 000000
> Total Liabilities 
250
6,931
10,329
9,253
3,560
7,059
7,0593,5609,25310,3296,931250
   > Total Current Liabilities 
6,563
6,563
10,329
12,415
3,560
7,059
7,0593,56012,41510,3296,5636,563
       Short-term Debt 
0
0
3,018
0
0
0
0003,01800
       Short Long Term Debt 
0
0
3,018
0
0
0
0003,01800
       Accounts payable 
6,563
6,563
4,326
9,909
3,560
7,059
7,0593,5609,9094,3266,5636,563
       Other Current Liabilities 
0
0
2,985
96
3,560
0
03,560962,98500
   > Long-term Liabilities 
0
368
0
-1
0
0
00-103680
> Total Stockholder Equity
25
36,282
29,915
20,233
14,898
6,558
6,55814,89820,23329,91536,28225
   Common Stock
702
702
702
702
14,898
6,558
6,55814,898702702702702
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
0
48,135
48,497
0
14,898
0
014,898048,49748,1350



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-178
Gross Profit-178-178
 
Operating Income (+$)
Gross Profit-178
Operating Expense-34,078
Operating Income-34,078-34,256
 
Operating Expense (+$)
Research Development-
Selling General Administrative40,644
Selling And Marketing Expenses-
Operating Expense34,07840,644
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Net Interest Income-0
 
Pretax Income (+$)
Operating Income-34,078
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-34,318-34,078
EBIT - interestExpense = -40,894
-34,318
-34,318
Interest Expense0
Earnings Before Interest and Taxes (ebit)-40,894-34,318
Earnings Before Interest and Taxes (ebitda)-34,078
 
After tax Income (+$)
Income Before Tax-34,318
Tax Provision--
Net Income From Continuing Ops-34,318-34,318
Net Income-34,318
Net Income Applicable To Common Shares-41,182
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses13,438
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
MWC.CC
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of MWC.CC.

MWC.CC Daily Candlestick Chart
MTC.CC
2 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of MTC.CC.

MTC.CC Daily Candlestick Chart
MOB.CC
4 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MOB.CC.

MOB.CC Daily Candlestick Chart
MAID.CC
12 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of MAID.CC.

MAID.CC Daily Candlestick Chart
LIKE.CC
18 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LIKE.CC.

LIKE.CC Daily Candlestick Chart
LBK.CC
19 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of LBK.CC.

LBK.CC Daily Candlestick Chart
JOINT.CC
24 minutes ago

I found you a Death Cross on the daily chart of JOINT.CC.

JOINT.CC Daily Candlestick Chart
ION.CC
27 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ION.CC.

ION.CC Daily Candlestick Chart
RV.V
33 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RV.V.

RV.V Daily Candlestick Chart
SCL.TO
35 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of SCL.TO.

SCL.TO Daily Candlestick Chart
PRU.TO
40 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PRU.TO.

PRU.TO Daily Candlestick Chart
XSQ.TO
46 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XSQ.TO.

XSQ.TO Daily Candlestick Chart
NA.TO
48 minutes ago

I found you a Golden Cross on the daily chart of NA.TO.

NA.TO Daily Candlestick Chart
MNT.TO
49 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MNT.TO.

MNT.TO Daily Candlestick Chart
MOGO.TO
49 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MOGO.TO.

MOGO.TO Daily Candlestick Chart
L.TO
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of L.TO.

L.TO Daily Candlestick Chart
HZD.TO
57 minutes ago

I found you a Death Cross on the daily chart of HZD.TO.

HZD.TO Daily Candlestick Chart
TLGN.PINK
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of TLGN.PINK.

TLGN.PINK Daily Candlestick Chart
GXE.TO
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GXE.TO.

GXE.TO Daily Candlestick Chart
NHK.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NHK.TO.

NHK.TO Daily Candlestick Chart
ZMU.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZMU.TO.

ZMU.TO Daily Candlestick Chart
PNPN.V
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PNPN.V.

PNPN.V Daily Candlestick Chart
TRL.TO
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of TRL.TO.

TRL.TO Daily Candlestick Chart
VBNK.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VBNK.TO.

VBNK.TO Daily Candlestick Chart
VCB.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VCB.TO.

VCB.TO Daily Candlestick Chart